P

Inventor

MATSCHINER GABRIELE

DE21 patents
⚠️ This page may combine multiple inventors who share the name “MATSCHINER GABRIELE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PIERIS PHARMACEUTICALS GMBH

11 patents
US10273275B2Apr 30, 2019

Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof

PIERIS PHARMACEUTICALS GMBH10 citations82
US10618941B2Apr 14, 2020

Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target

PIERIS PHARMACEUTICALS GMBH6 citations81
US9687524B2Jun 27, 2017

Tear lipocalin muteins binding IL-4 R alpha

PIERIS PHARMACEUTICALS GMBH6 citations81
US10526384B2Jan 7, 2020

Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof

PIERIS PHARMACEUTICALS GMBH5 citations72
US10400016B2Sep 3, 2019

Proteins specific for calcitonin gene-related peptide

PIERIS PHARMACEUTICALS GMBH4 citations71
US10232014B2Mar 19, 2019

Tear lipocalin muteins binding IL-4 R alpha

PIERIS PHARMACEUTICALS GMBH3 citations70
US11034737B2Jun 15, 2021

Proteins specific for calcitonin gene-related peptide

PIERIS PHARMACEUTICALS GMBH1 citations61
US11827681B2Nov 28, 2023

Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target

PIERIS PHARMACEUTICALS GMBH0 citations59
US10927154B2Feb 23, 2021

Multi-specific polypeptide useful for localized tumor immunomodulation

PIERIS PHARMACEUTICALS GMBH1 citations58
US9751920B2Sep 5, 2017

Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same

PIERIS PHARMACEUTICALS GMBH0 citations51
US10787491B2Sep 29, 2020

Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)

PIERIS PHARMACEUTICALS GMBH0 citations50

MATSCHINER GABRIELE

3 patents

PIERIS AG

2 patents

SKERRA ARNE

1 patent

TRENTMANN STEFAN

1 patent

HOHLBAUM ANDREAS

1 patent

ASTRAZENECA AB

1 patent

DAIICHI SANKYO CO LTD

1 patent